Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
About BIO | BIO
We promote biomedical innovation by developing and advocating for public policies that represent the best interests of members focused on human health. We break-down the barriers that impede American innovation by reducing bureaucratic hurdles to lifesaving technologies.
Senior Leadership Team at BIO
Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Industry Analysis Reports - BIO
This report investigates recent investment into antibacterial innovation and the current clinical pipeline that will help bridge the gaps in the antibacterial armamentarium.
What is Biotechnology? | BIO
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.
BIO's Priorities | BIO
Explore how we drive biotechnology innovation. Advancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company.
New BIO Report Finds More Innovation & Investment Needed in …
2024年1月25日 · Today, the Biotechnology Innovation Organization (BIO) released a new report, "The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases," examining the latest scientific and investment trends in vaccine development.
Press Releases - BIO
Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic performance, its impacts, and its geographic…
BIO Events | BIO
As the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and empower biotech innovators and their ecosystem to improve lives, but also offer a broad and unbiased venue to seek investment and BD&L opportunities.
Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases by David Thomas, CFA and Chad Wessel BIO INDUSTRY ANALYSIS December 2023